Skip to main content

Table 1 Common and potent antiviral drugs

From: The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status

Status

Drugs

Action mode

Anti-infective mechanism

Target diseases

Ref.

Approved

Lopinavir/Ritonavir

Protease inhibitors

Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious, immature viral particles

HIV/AIDS, SARS, MERS

[83,84,85]

Approved, Investigational, Vet approved

Chloroquine

9-aminoquinolin

Increasing endosomal pH, immunomodulating, autophagy inhibitors

Malaria, autoimmune disease

[79,80,81,82]

Experimental

Remdesivir (GS-5734)

Nucleotide analogue prodrug

Interfering with virus post-entry

Ebola, SARS, MERS

(A wide array of RNA viruses)

[76, 88, 89]

Investigational

Nafamostat

Synthetic serine protease inhibitor

Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities

Influenza, MERS, Ebola

[90, 91]

Approved

Ribavirin

Synthetic guanosine nucleoside

Interfering with the synthesis of viral mRNA (a broad-spectrum activity against several RNA and DNA viruses)

HCV, SARS, MERS

[92,93,94]

Approved

Oseltamivir

Neuraminidase inhibitor

Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity

Influenza viruses A

[95, 96]

Approved

Penciclovir/ Acyclovir

Nucleoside analog

A synthetic acyclic guanine derivative, resulting in chain termination

HSV, VZV

[97]

Approved, Investigational

Ganciclovir

Nucleoside analog

Potent inhibitor of the Herpesvirus family including cytomegalovirus

AIDS-associated cytomegalovirus infections

[98]

Investigational

Favipiravir (T-705)

Nucleoside analog: Viral RNA polymerase inhibitor

Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis

Ebola, influenza A(H1N1)

[99,100,101]

Approved, Investigational, Vet approved

Nitazoxanide

Antiprotozoal agent

Modulating the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses

A wide range of viruses including human/animal coronaviruses

[102,103,104]

  1. HIV Human immunodeficiency virus, AIDS Acquired immune deficiency syndrome, SARS Severe acute respiratory syndrome, MERS Middle East respiratory syndrome, HCV Hepatitis C virus, HSV Herpes simplex virus, VZV Varicella-zoster virus